Θεοδώρα Παππά

Dana-Farber Cancer Institute — United States

Medicine · Health Sciences

23h-index2.1kcitations144works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Thyroid Cancer Diagnosis and Treatment(71), Thyroid Disorders and Treatments(16), BRCA gene mutations in cancer(15), Hormonal Regulation and Hypertension(15), Pituitary Gland Disorders and Treatments(14)

Publications143 total

Supplementary Table S3 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2024Open Access
Supplementary Table S2 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2024Open Access
Supplementary Table S1 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2024Open Access
An update on redifferentiation strategies for radioactive iodine-refractory differentiated thyroid carcinoma
Endocrine·2024· 2 cited
A Phase I/II Trial of Sapanisertib in Advanced Anaplastic and Radioiodine Refractory Differentiated Thyroid Carcinoma
The Journal of Clinical Endocrinology & Metabolism·2024· 6 cited
Dual immune checkpoint inhibition with nivolumab and ipilimumab (N+I) in patients with advanced anaplastic thyroid carcinoma (ATC).
Journal of Clinical Oncology·2024· 2 cited
Phase II trial of regorafenib in metastatic medullary thyroid carcinoma (MTC) and radioactive iodine refractory differentiated thyroid carcinoma (RAIR DTC).
Journal of Clinical Oncology·2024· 1 cited
STR mutations on chromosome 15q cause thyrotropin resistance by activating a primate-specific enhancer of MIR7-2/MIR1179
Nature Genetics·2024· 22 citedOpen Access
What Is the Impact of Adding Immune Checkpoint Inhibition to Dabrafenib/Trametinib in <i>BRAF</i> -Mutant Anaplastic Thyroid Carcinoma?
Clinical Thyroidology·2024
Completion Thyroidectomy May Not Always Be Necessary in the Setting of Incidental Metastatic Lymph Nodes
Clinical Thyroidology·2024
Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules
The Journal of Clinical Endocrinology & Metabolism·2024· 8 citedOpen Access
Artificial Intelligence as a Screening Tool to Detect Severity of Thyroid Eye Disease
Clinical Thyroidology·2024
P229: Non-coding variants create an enhancer cluster that causes resistance to thyrotropin via long-range interactions with a microRNA promoter
Genetics in Medicine Open·2024Open Access
MERAIODE: A Phase II Redifferentiation Trial with Trametinib and <sup>131</sup> I in Metastatic Radioactive Iodine-Refractory RAS-Mutated Differentiated Thyroid Cancers
Clinical Thyroidology·2023
Supplementary Table S3 from Additional Oncogenic Alterations in &lt;i&gt;RAS&lt;/i&gt;-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2023Open Access
Data from Additional Oncogenic Alterations in &lt;i&gt;RAS&lt;/i&gt;-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2023Open Access
Supplementary Table S2 from Additional Oncogenic Alterations in &lt;i&gt;RAS&lt;/i&gt;-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2023Open Access
Supplementary Table S2 from Additional Oncogenic Alterations in &lt;i&gt;RAS&lt;/i&gt;-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2023Open Access
Supplementary Table S1 from Additional Oncogenic Alterations in &lt;i&gt;RAS&lt;/i&gt;-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2023Open Access
Supplementary Table S1 from Additional Oncogenic Alterations in &lt;i&gt;RAS&lt;/i&gt;-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2023Open Access
← Previouspage 2 of 8Next →

Frequent Co-authors

George Piaditis(15), Labrini Papanastasiou(11), Maria Alevizaki(10), Samuel Refetoff(10), Αthina Markou(9), Gregory Kaltsas(9), Erik K. Alexander(8), Sara Ahmadi(7), Ellen Marqusee(7), Iñigo Landa(7), Vaios Tsiavos(5), Ioannis I. Androulakis(5), Athanasios Bikas(5), George P. Chrousos(4), Stelios Fountoulakis(4), Justine A. Barletta(4), Roy E. Weiss(4), Alexandra M. Dumitrescu(4), Christianna Samara(4), Georgios Papadakis(4)